SCHEMBL22177482

SCHEMBL22177482

c1ccc(-c2nc(-c3cccc4c3sc3ccccc34)nc(-c3cccc4sc5ccc(-c6ccc(-c7nc8ccccc8o7)cc6)cc5c34)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.38
RAB9A P51151 6/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
ATM Q13315 1/20 0.38
KDM4E B2RXH2 6/20 0.37
ALDH1A1 P00352 6/20 0.37
HPGD P15428 6/20 0.37
MAPT P10636 6/20 0.37
SMN1; SMN2 Q16637 5/20 0.37
TP53 P04637 3/20 0.37
GAA P10253 2/20 0.37
NFKB1 P19838 2/20 0.37
NFKB2 Q00653 2/20 0.37
RELA Q04206 2/20 0.37
LMNA P02545 1/20 0.37
STAT1 P42224 1/20 0.37
GFER P55789 1/20 0.37
HSD17B10 Q99714 3/20 0.36
USP2 O75604 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22736055 0.96 NPC1 (0.38) NPC1RAB9AMEN1KMT2AATM
SCHEMBL22178031 0.96 KDM4E (0.39) NPC1RAB9AMEN1KMT2AATM
SCHEMBL22177451 0.96 KDM4E (0.41) NPC1RAB9AMEN1KMT2AATM
SCHEMBL22736409 0.94 NPC1 (0.38) NPC1RAB9AMEN1KMT2AATM
SCHEMBL22177905 0.94 KDM4E (0.40) NPC1RAB9AMEN1KMT2AATM
SCHEMBL22177483 0.94 NPC1 (0.40) NPC1RAB9AMEN1KMT2AATM
SCHEMBL22177488 0.94 NPC1 (0.42) NPC1RAB9AMEN1KMT2AATM
SCHEMBL22736056 0.94 NPC1 (0.42) NPC1RAB9AMEN1KMT2AATM
SCHEMBL22177954 0.94 NPC1 (0.43) NPC1RAB9AMEN1KMT2AATM
SCHEMBL22177957 0.94 NPC1 (0.43) NPC1RAB9AMEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11518769-B2 Heterocyclic compounds and organic light emitting device using the same LG CHEM, LTD. (KR) 2022-12-06 US disclosed
US-20200207754-A1 NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2020-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200207754-A1 NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, CRY2, CYP1A1 NPC1 2337/4885RAB9A 2411/4885MEN1 344/4885
US-11518769-B2 Heterocyclic compounds and organic light emitting device using the same CRY1, CYP1A1, CRY2 NPC1 2044/4885RAB9A 2545/4885MEN1 342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.